Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Capital Expenditures (2016 - 2025)

Lifevantage (LFVN) has disclosed Capital Expenditures for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 120.33% year-over-year to $1.1 million, compared with a TTM value of $2.1 million through Dec 2025, up 45.6%, and an annual FY2025 reading of $1.4 million, down 38.93% over the prior year.
  • Capital Expenditures was $1.1 million for Q4 2025 at Lifevantage, up from $439000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.9 million in Q1 2021 and bottomed at $199000.0 in Q2 2025.
  • Average Capital Expenditures over 5 years is $606400.0, with a median of $486000.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures surged 303.38% in 2021, then tumbled 80.91% in 2022.
  • Year by year, Capital Expenditures stood at $521000.0 in 2021, then surged by 60.65% to $837000.0 in 2022, then tumbled by 35.13% to $543000.0 in 2023, then decreased by 9.39% to $492000.0 in 2024, then soared by 120.33% to $1.1 million in 2025.
  • Business Quant data shows Capital Expenditures for LFVN at $1.1 million in Q4 2025, $439000.0 in Q3 2025, and $199000.0 in Q2 2025.